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Can multilayer speckle imaging help in the aetiological diagnosis of
LVH?
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Purpose Aetiological diagnosis of LV hypertrophy (LVH) by standard
echocardiography is sometimes difficult and the analysis of strain in different
myocardial layers using 2D speckle imaging may provide valuable diagnostic
information.
Methods Measurements of subendocardial (SEndo), subepicardial (SEpi)
and global (G) longitudinal strain (LS)(%) were performed (GE EchoPac)
from the 3 apical views recorded in 24 normal pts (Nl), 19 pts with cardiac
amyloidosis (CA) and 23 pts with hypertrophic cardiomyopathy (HCM) with
preserved LV ejection fraction (ED septal thickness CA 18±3mm vs HCM
21±5mm, ns).
Results A transmural gradient exists in LS with significantly higher values
in the subendocardial layer in all pts, but this gradient is significantly less pro-
nounced among CA pts.
All strain values were significantly different by Anova analysis between
the 3 groups. Subanalysis by Bonferroni test showed significantly lower
values of all strain measurements in pts with CA as compared to both Nl and
HCM pts. However, this trend toward lower strain values was not significant
between HCM and Nl pts for SendoLS and GLS. Analysis of ROC curves
among pts with LVH showed that SEndoLS, SEpiLS, GLS and transmural
gradient were all good predictors of CA (Areas under Curves respectively
0.84, 0.86, 0.85, 0.78, all p<0.001).
Conclusion Analysis of multilayer longitudinal deformation by 2D speckle
imaging confirms the presence of a significant transmural gradient of strain
values, significantly less pronounced in CA pts than in Nl and HCM pts. As
compared to Nl pts, the decrease of strain values is more severe in CA pts than
in HCM pts, despite a non-significant trend tower lower value of septal thick-
ness in CA. Furthermore, global subendocardial LS seems relatively preserved
in HCM pts as compared to Nl pts. These findings, along with further analysis
of segmental multilayer deformation, are probably interesting adjuncts in the
process of the aetiological diagnosis of LVH
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Borderline hypertrophic cardiomyopathy or athlete’s heart: what is
the role for imaging and genetic testing in athletes?
Nicolas Mansencal*, Maria Arslan, P. Richard, S. Guerard, R. Brion,
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Background Intensive exercise is associated with a modest increase in left
ventricular wall thickness (LVWT). In some cases, a doubt may occur
between an athlete’s heart and hypertrophic cardiomyopathy (HCM). The aim
of the study was to assess the accuracy and role of imaging and genetic testing
to distinguish athlete’s heart from borderline HCM and make a decision
regarding sport/professional activity.
Methods We studied consecutive athletes (intensive sport >10 hours/weeks;
LVWT between 12 to 16mm) with a suspicion of borderline HCM according
to the clinical status and cardiac examinations. We studied the accuracy of
local cardiac diagnostic assessment versus expert referral center (cardiac
assessment blinded to the results of local assessment) versus results of genetic
testing (analysis of the 5 main sarcomeric genes). All cardiac local and expert
assessments were performed according to ECG, echocardiography, exercise
test and CMR (when available) and were blinded to genetic results.
Results 37 athletes (35 men) were enrolled, mean age: 28±12 years, mean
LVWT was 13.6±1,2mm. A causative mutation was identified in 27% (10/37)
of athletes: among these 10 subjects, 8 had a cardiac diagnosis of suspected
HCM and 2 had a suspected diagnosis of athletes heart. Genetic testing recti-
fied cardiac assessment in 5.4% of our population. Local cardiac evaluation
suspected HCM in 70% (n=26, only 31% with a mutation) versus 46% (n=17,
47% with a mutation) in expert center (p=0.03). In subjects without identified
genetic mutation, HCM was suspected in 67% of cases in local center versus
33% in expert center (p=0.01).
Conclusions In borderline HCM/athlete’s heart, imaging should be associ-
ated with genetic testing. Genetic testing was able to confirm the diagnosis of
HCM in 27%, including the rectification of imaging assessment in 5.4%. Our
results suggest that genetic testing may have a role in athletes with a suspicion
of borderline HCM.
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Assessment of diastolic function by myocardial deformation tech-
niques in hypertrophic cardiomyopathy
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Background Diastolic dysfunction in hypertrophic cardiomyopathy is
common, and its assessment by conventional echocardiographic parameters is
difficult. Myocardial deformation techniques can be used to analyse atrial
function, and therefore diastolic function. The aim of this study is to assess
atrial function in hypertrophic cardiomyopathy by longitudinal atrial strain.
Methods We included 48 consecutive patients with hypertrophic cardio-
myopathy (HCM group) and 48 normal subjects (control group), who under-
went transthoracic echocardiography. The following echocardiographic
parameters were systematically assessed in the two groups: mitral E-wave and
A-wave velocities, Tissue Doppler Imaging of the mitral annulus, left atrial
size, longitudinal strain of the left ventricle and longitudinal strain of the left
atrium. Clinical status of HCM was always assessed (NYHA class).
Results Mean age was 43±19 y.o. in each group (men: 69%). NYHA class
was as follows in HCM group: class I in 46%, II in 31%, III in 29% and IV
in 4%. Conventional echocardiographic parameters were significantly dif-
ferent in HCM as compared to control group. However, these parameters were
not related to symptoms (NYHA class). Using longitudinal strain of the left
atrium, end-systolic peak of left atrial longitudinal strain (ESAS) and early-
diastolic left atrial longitudinal strain were altered in hypertrophic cardio-
myopathy, reflecting respectively reservoir and conduit functions. ESAS was
the best parameter for detecting diastolic function in HCM with a cut-off value
of 15.5% (ROC curves) and was significantly correlated to symptoms (r=0.49,
p=0.0008). Sensitivity, specificity, PPV and NPV of ESAS for predicting
severe symptoms (NYHA class III and IV) were 71%, 79%, 77% and 73%,
respectively.
Conclusion End-systolic peak of left atrial longitudinal strain is a reliable
echocardiographic parameter for the assessment of diastolic function in hyper-
trophic cardiomyopathy.
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